Equities
Improved Notifications for Markets Data Alerts
Improved Notifications for Markets Data Alerts
Want push notifications sent directly to your devices for equity price changes and breaking news stories? Let us know here.
 
Existing alertsView our existing alerts
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Siemens Healthineers AG is a Germany-based company that supplies technology to the healthcare industry. The Company offers a wide range of products and services in the fields of diagnostic and therapeutic imaging, laboratory and point of care diagnostics, and molecular medicine. It provides medical technology and software solutions, as well as clinical consulting services. Additionally, the Company develops its digital health and enterprise services trough expanding precision medicine, transforming care delivery, improving patient experience, and digitalizing healthcare. The Company is active worldwide.

  • Revenue in EUR (TTM)21.87bn
  • Net income in EUR1.84bn
  • Incorporated2017
  • Employees71.80k
More ▼

Institutional shareholders

4.77%Per cent of shares held by top holders
HolderShares% Held
The Vanguard Group, Inc.as of 04 Jul 20249.72m0.86%
Capital Research & Management Co. (World Investors)as of 30 Jun 20247.19m0.64%
Norges Bank Investment Managementas of 31 Dec 20237.07m0.63%
Fidelity Management & Research Co. LLCas of 31 May 20246.45m0.57%
BlackRock Fund Advisorsas of 04 Jul 20244.99m0.44%
Capital International Ltd.as of 30 Jun 20244.76m0.42%
Candriam Belgium SAas of 30 Jun 20244.10m0.36%
T. Rowe Price Associates, Inc. (Investment Management)as of 30 Jun 20243.94m0.35%
BlackRock Asset Management Deutschland AGas of 05 Jul 20243.41m0.30%
BlackRock Advisors (UK) Ltd.as of 04 Jul 20242.21m0.20%
More ▼
Data from 31 Dec 2023 - 31 Mar 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.